| Alyssa Noriko Nii, | |
|
45-480 Kaneohe Bay Dr, Kaneohe, HI 96744-2039 | |
| (808) 235-5805 | |
| Not Available |
| Full Name | Alyssa Noriko Nii |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 45-480 Kaneohe Bay Dr, Kaneohe, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033617287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4251 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Noriko Nii, 45-480 Kaneohe Bay Dr, Kaneohe, HI 96744-2039 Ph: (808) 235-5805 | Alyssa Noriko Nii, 45-480 Kaneohe Bay Dr, Kaneohe, HI 96744-2039 Ph: (808) 235-5805 |
News Archive
Benign vascular malformations known as cavernomas can occur in many tissues of the body. These abnormalities are characterized by enlarged, instable and unstructured blood vessels. Cavernomas of medical relevance are primarily those of the brain, which develop approximately in one out of two hundred people. In the brain, such growths often remain unnoticed and are typically found by chance in MRI scans. If they grow larger, they often cause unspecific symptoms such as headaches or dizziness.
A new Mayo Clinic study shows that variations in the serotonin transporter gene could explain why some people with depression respond better than others to treatment with citalopram (Celexa), an antidepressant medication.
Bowel screening reduces the number of deaths from bowel cancer in Scotland by more than 25 per cent, according to research* presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.
Answering an urgent call for assistance from regional health care systems, a volunteer team of scientists at the University of Massachusetts Amherst is preparing, testing and delivering thousands of vials of viral transport media, a chemical solution needed for COVID-19 diagnostic testing.
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.
› Verified 4 days ago
Lia Fukada, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45-480 Kaneohe Bay Dr Bldg E, Kaneohe, HI 96744 Phone: 808-235-5805 | |
Mark Mierzwa, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45-710 Keaahala Rd, Building G - Pharmacy, Kaneohe, HI 96744 Phone: 808-236-8350 Fax: 808-247-2037 | |
Mr. Derek Ren Okamura, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45-934 Kamehameha Hwy, Kaneohe, HI 96744 Phone: 808-233-4601 Fax: 808-233-4627 | |
Mrs. Cara Lynn Nishida-todd, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45-602 Kamehameha Hwy, Kaneohe, HI 96744 Phone: 808-432-3853 Fax: 808-432-3854 | |
Kelsey K Chang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45-480 Kaneohe Bay Dr, Kaneohe, HI 96744 Phone: 808-235-5805 | |
Tiana Kenna Tran, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 46-021 Kamehameha Hwy, Kaneohe, HI 96744 Phone: 808-234-1490 |